The article highlights the significant progress made in HIV treatment, particularly the development of lenacapavir, a drug exhibiting unprecedented efficacy in clinical trials. Despite past advancements that transformed HIV into a manageable condition, challenges remain with new infections reaching 1.3 million in 2023 alone. Lenacapavir, tested on thousands, demonstrated a remarkable ability to prevent infections, with a notable trial showing zero cases among young women administered the drug over a year. This represents a hopeful turning point in the battle against HIV, promising to further enhance prevention methods.
More than two thousand teen girls and young women had been injected with the drug, which stays in the body for an astonishing six months.
We thought it was going to work, but none of us thought it was going to be one hundred per cent.
In 2023, almost forty million people were living with H.I.V., and six hundred and thirty thousand died from AIDS.
In 2023, 1.3 million people around the world became infected—more than thirty-five hundred per day, nearly a hundred and fifty every hour.
Collection
[
|
...
]